Top 30 Pharmaceutical Companies in Massachusetts

5 min read

Get started

Trusted by data-driven investors

Massachusetts is home to a thriving pharmaceutical industry, with leading companies pushing the boundaries of drug discovery and biopharmaceutical advancements. From cannabinoid-based therapies by Targeted Pharmaceuticals in Worcester to oncology-focused innovations by TESARO in Waltham, these firms are at the forefront of cutting-edge research in personalized medicine and biotech. Investment opportunities abound in sectors such as oncology, neurology, and antimicrobial resistance, driven by Massachusetts' robust ecosystem of publicly traded companies and dynamic startups.

Targeted Pharmaceuticals logo

Targeted Pharmaceuticals

🇺🇸 60 Prescott St Worcester, Massachusetts 01605, US

Targeted Pharmaceuticals specializes in cannabinoid-based drug discovery and personalized medicine within the pharmaceutical manufacturing industry, focusing on innovative approaches to developing tailored therapeutic solutions.

cannabinoids
pharmaceuticals
marijuana
drug
discovery
medicine
targeted
personalized
therapies
treatments
cannabis
biopharmaceuticals
innovation
research
development
formulations
clinical
efficacy
dosage
extraction
Company size: 2-10
Founded: 2018
ARIAD Pharmaceuticals, Inc. logo

ARIAD Pharmaceuticals, Inc.

🇺🇸 26 Landsdowne Street Cambridge, Massachusetts 02139, US

ARIAD Pharmaceuticals specializes in pharmaceutical manufacturing with a focus on oncology and innovative drug development, leveraging biotechnology to advance cancer treatments.

pharmaceutical
biotech
biotechnology
oncology
cancer
drug development
Company size: 201-500
Founded: 1991
Cubist Pharmaceuticals logo

Cubist Pharmaceuticals

🇺🇸 65 Hayden Avenue Lexington, MA 02421, US

Cubist Pharmaceuticals specializes in pharmaceutical manufacturing, focusing on innovative solutions for infectious diseases. As a subsidiary of Merck & Co., it leverages advanced research and development capabilities to enhance treatment options in the healthcare sector.

pharmaceuticals
manufacturing
biotechnology
healthcare
drug development
therapeutics
clinical research
biopharmaceuticals
Company size: 1001-5000
Founded: 1992
TESARO, Inc. logo

TESARO, Inc.

🇺🇸 1000 Winter St Waltham, Massachusetts 02451, US

TESARO is an oncology-focused biopharmaceutical firm dedicated to enhancing the cancer care experience through innovative drug development and commercialization. Their mission emphasizes a patient-first approach, fostering a culture of unconditional care and commitment to advancing oncology treatments.

pharmaceuticals
oncology
biopharmaceuticals
drug development
drug commercialization
cancer care
Company size: 501-1000
BioXchange logo

BioXchange

🇺🇸 Kendall Square Boston, MA 02139, US

BioXchange is a leading networking organization in the biotechnology research sector, focused on connecting individuals and companies within the life sciences community through specialized events. It leverages its extensive network to foster collaboration across various industry sectors, including pharmaceuticals and drug discovery.

networking
biotechnology
pharmaceuticals
life sciences
drug discovery
research
drug development
biotech
Company size: 2-10
Founded: 2018
Samyang Biopharm USA logo

Samyang Biopharm USA

🇺🇸 600 One Kendall Square Suite 202

Specializing in biotechnology research, Samyang Biopharm USA focuses on out-licensing innovative nucleic acid drug delivery systems and aims to establish partnerships and co-development ventures with pharmaceutical firms in the U.S.

biotechnology
drug delivery
nucleic acid
biopharmaceuticals
out-licensing
partnerships
joint ventures
research
Company size: 2-10
Founded: 2018
Oxeia Biopharmaceuticals Inc logo

Oxeia Biopharmaceuticals Inc

🇺🇸 361 Newbury St Boston, Massachusetts 02115, US

Oxeia Biopharmaceuticals is focused on developing innovative therapeutics for mild traumatic brain injury (concussion) and related neuro-metabolic dysfunction, with a clinical-stage drug, OXE103, currently undergoing Phase 2 trials. Their unique approach addresses a significant gap in treatment options for concussion patients, emphasizing the need for more than just rest.

biotechnology
therapeutics
clinical trials
mild traumatic brain injury
neuro-metabolic dysfunction
concussion
drug development
Company size: 2-10
Founded: 2014

VDA Pharma, Inc.

🇺🇸 108 MARLBOROUGH ST Boston, Massachusetts 02116, us

VDA Pharma, Inc. specializes in the manufacturing of biopharmaceuticals focused on HIV treatment, leveraging innovative approaches to develop effective therapies in the pharmaceutical industry.

pharmaceuticals
biopharmaceuticals
HIV
manufacturing
drug development
healthcare
biotechnology
therapeutics
Company size: 2-10
Founded: 2011
NeuForm Pharmaceuticals, Inc. logo

NeuForm Pharmaceuticals, Inc.

🇺🇸 1661 Worcester St., Suite 102 Framingham, MA 01701, US

NeuForm Pharmaceuticals specializes in innovative drug discovery within the biopharmaceutical sector, developing proprietary and patent-protected candidates targeting oncology, neurology, immunology, and metabolic diseases. The organization emphasizes collaboration with top academic and clinical experts to deliver best-in-class medicines to patients.

biopharmaceuticals
drug discovery
oncology
neurology
immunology
metabolic diseases
clinical research
patent protection
innovative therapies
academic collaboration
Company size: 2-10
Founded: 2014
NeuroSense Therapeutics logo

NeuroSense Therapeutics

🇺🇸 1 Broadway Cambridge, Massachusetts 02142, US

NeuroSense Therapeutics is a clinical-stage biotechnology firm dedicated to advancing innovative treatments for ALS and other neurodegenerative diseases, employing a rigorous approach through its Phase 2b clinical study. Its focus on developing groundbreaking therapies positions it at the forefront of the biopharmaceutical industry.

biotechnology
drug development
ALS
neurodegenerative
CNS
biopharmaceuticals
clinical trials
treatment
Parkinson's
Alzheimer's
MND
research
Company size: 11-50
Founded: 2017
Sanyou Biopharmaceuticals logo

Sanyou Biopharmaceuticals

🇺🇸 1 Broadway, 14th floor, Cambridge, MA 02142 Cambridge, MA 02142, US

Sanyou Biopharmaceuticals specializes in biotechnology research, focusing on the research, development, and manufacturing of innovative biologics and reagents. Utilizing a unique 4C business model, it offers comprehensive services across the drug development lifecycle while ensuring high-quality standards through rigorous certifications.

biotechnology
drug R&D
biologics
CRO
CDMO
antibody drug
drug discovery
phage display
antibody engineering
GMP
high throughput screening
antibody-drug conjugates
Company size: 201-500
Founded: 2015
Infinity Pharmaceuticals logo

Infinity Pharmaceuticals

🇺🇸 Cambridge, Massachusetts 02138, US

Infinity Pharmaceuticals specializes in the development and manufacturing of innovative oncology therapies, focusing on small molecules and immuno-oncology solutions. Their commitment to advancing cancer treatment positions them as a key player in the pharmaceutical manufacturing industry.

pharmaceuticals
oncology
small molecule
immuno-oncology
drug development
biopharmaceuticals
Company size: 201-500
Founded: 2001
Javelin Biotech logo

Javelin Biotech

🇺🇸 299 Washinton St Woburn, MA- MASSACHUSETTS 01801, US

Javelin Biotech specializes in biotechnology research, developing predictive drug discovery platforms that integrate human and computational biology to enhance preclinical drug discovery and increase drug approval rates.

biotechnology
drug discovery
predictive modeling
computational biology
preclinical research
human biology
drug approval
Company size: 11-50
Wild Biotech logo

Wild Biotech

🇺🇸 Boston, US

Wild Biotech is a biotechnology research firm specializing in drug discovery, leveraging innovative approaches to develop resilient therapeutic solutions.

biotechnology
drug discovery
research
pharmaceuticals
healthcare
innovation
therapeutics
Company size: 2-10
Founded: 2019

A consultancy specializing in biotechnology research and strategy, focusing on storytelling and drafting business sections for NASDAQ IPOs. Notable for its success in helping clients raise significant capital through public offerings, it offers expertise in market research and investor pitches tailored for the life sciences sector.

biotechnology
life sciences
strategy consulting
market research
investor pitches
drug discovery
pharmaceuticals
NASDAQ IPOs
venture capital
Company size: 2-10
Founded: 2003
Immunocan logo

Immunocan

🇺🇸 625 Massachusetts Ave Cambridge, Massachusetts 02139, US

Immunocan specializes in biotechnology research, focusing on innovative gene-edited animal platforms for the discovery of fully human and alpaca antibodies, enhancing antibody drug R&D across diverse scenarios.

biotechnology
gene editing
antibody discovery
drug development
research platform
animal models
human antibodies
alpaca antibodies
Company size: 51-200
Founded: 2021
Trevie Research logo

Trevie Research

🇺🇸 245 First Street Riverview II 18th Floor

Trevie Research specializes in oncology-focused clinical development and trial management, offering expert advisory services in biopharma drug development and commercialization. The firm leverages extensive experience and strong relationships with key opinion leaders to support Phase I/II drug development programs for biotech, pharmaceutical, and non-profit organizations.

biotechnology
oncology
clinical development
trial management
biopharma
drug development
commercialization
trial operations
Phase I
Phase II
KOLs
academia
Company size: 11-50
Founded: 2014
Phosphorex logo

Phosphorex

🇺🇸 35 Parkwood Drive Suite 210

Phosphorex specializes in biotechnology research, focusing on innovative drug delivery solutions for the pharmaceutical and biopharmaceutical sectors. Their unique offerings include advanced techniques such as microencapsulation, nanosizing, and surface functionalization, enabling controlled release and targeted delivery of active pharmaceutical ingredients while enhancing solubility and bioavailability.

drug delivery
nanomedicine
microencapsulation
nanosizing
microemulsion
surface functionalization
targeted delivery
controlled release
biopharmaceuticals
vaccine development
gene delivery
oligonucleotide
Company size: 11-50
Founded: 2005
AP Biosciences logo

AP Biosciences

🇺🇸 23 Main Street Floor 3k

AP Biosciences specializes in biotechnology research by providing staffing solutions, including direct hires, contract placements, and consulting services, specifically tailored for the drug development and medical device sectors. Their consultative approach ensures optimal technical and cultural alignment, addressing a wide range of specialties such as regulatory affairs, quality assurance, and biopharmaceuticals.

biotechnology
drug development
medical devices
staffing
regulatory affairs
quality assurance
compliance engineering
biopharmaceuticals
pharmaceuticals
project management
pharmacovigilance
research and development
Company size: 2-10
Founded: 2019
American Society of Pharmacovigilance Physicians logo

American Society of Pharmacovigilance Physicians

🇺🇸 Boston, MA 02143, US

A national medical specialty society dedicated to promoting best practices in pharmacovigilance, focusing on the detection and prevention of drug-related adverse effects. It offers training programs and co-sponsors conferences, catering to physicians and clinicians in the pharmaceutical and biotech industries.

pharmacovigilance
adverse effects
drug safety
risk assessment
professional society
training programs
medical specialty
clinical research
biotechnology
drug-related problems
Company size: 51-200
Founded: 2019
AMR Action Fund logo

AMR Action Fund

🇺🇸 Boston, Massachusetts, US

The AMR Action Fund is a pioneering venture capital fund focused on advancing the development of innovative antimicrobials, including antibiotics and anti-fungals, to combat drug-resistant pathogens. By investing $1 billion to bring 2 to 4 new treatments to market by 2030, it addresses critical healthcare challenges while advocating for essential market reforms.

venture capital
private equity
healthcare
biotech
pharmaceuticals
antibiotics
antimicrobials
drug resistance
investment
research
development
market reform
Company size: 11-50
Founded: 2020
Kumuda logo

Kumuda

🇺🇸 Boston, US

Kumuda specializes in biotechnology research, focusing on accelerating novel drug discovery and the development of new treatments for patients through actionable insights. Its innovative approach enhances the efficiency and effectiveness of the drug development process.

biotechnology
drug discovery
research
insights
treatment development
pharmaceuticals
Company size: 2-10
CoralBio Therapeutics, Inc. logo

CoralBio Therapeutics, Inc.

🇺🇸 Boston, US

CoralBio Therapeutics specializes in biotechnology research, offering pre-clinical and in vitro assay consulting services to assist clients in drug discovery, particularly in the fields of hematology and immunology. Their innovative approach includes providing scientific validation for lead molecules targeting inflammation, thrombosis, hemostasis, and bleeding disorders.

biotechnology
consulting
drug discovery
pre-clinical
assay development
scientific validation
inflammation
thrombosis
hemostasis
hematology
immunology
therapeutics
Company size: 1
Cotinga Pharmaceuticals Inc logo

Cotinga Pharmaceuticals Inc

🇺🇸 ---- Boston, Massachusetts, ca

Specializing in pharmaceutical manufacturing, Cotinga Pharmaceuticals leverages its innovative CHEMSAS artificial intelligence platform for algorithmic drug discovery and development, focusing on identifying high-potential compounds for cancer treatment through advanced predictive modeling and chemical optimization.

algorithmic drug discovery
biopharmaceuticals
artificial intelligence
predictive modeling
compound identification
chemical optimization
preclinical testing
small molecules
cancer treatment
drug candidate discovery
disease targeting
Company size: 2-10
Founded: 2008
TAC Biopharmaceuticals LLC logo

TAC Biopharmaceuticals LLC

🇺🇸 Malden, MA 02148, US

TAC Biopharmaceuticals specializes in biotechnology research, offering a comprehensive suite of services that support the development and commercialization of biopharmaceuticals, including generic drugs and biosimilars. With over 25 years of industry experience and a strong emphasis on regulatory expertise and strategic guidance, it empowers clients to navigate the complexities of modern medicine development.

biotechnology
pharmaceutical
biopharmaceutical
regulatory affairs
clinical development
non-clinical development
generic drugs
biosimilars
translational science
project management
business development
strategy development
Company size: 2-10
Founded: 2024
Tufts Center for the Study of Drug Development logo

Tufts Center for the Study of Drug Development

🇺🇸 145 Harrison Ave Boston, Massachusetts 02111, US

An independent, academic research center focused on enhancing the quality and efficiency of pharmaceutical and biopharmaceutical development, regulation, and utilization through strategic information and innovative research. It serves as a vital resource for stakeholders in the industry, regulatory agencies, and public policy, while fostering dialogue on critical issues affecting drug development globally.

pharmaceutical
biopharmaceutical
research
regulation
drug development
public policy
innovation
economic analysis
therapeutic agents
information resource
stakeholder engagement
strategic information
Company size: 11-50
Founded: 1976
Kira Pharmaceuticals logo

Kira Pharmaceuticals

🇺🇸 Cambridge, MA, US

Kira Pharmaceuticals is a clinical-stage biotechnology firm focused on pioneering innovative therapies to address complement diseases. Utilizing its proprietary LOGIC platform, it has developed a diverse pipeline of novel treatments targeting the complement cascade, positioning itself to deliver first-in-class and best-in-class solutions in the field of immunology and oncology.

biotechnology
pharmaceuticals
complement
immunology
oncology
drug development
clinical research
protein engineering
therapeutic pipeline
complement cascade
Company size: 11-50
Founded: 2017
PeptiFinder Biotech, Inc logo

PeptiFinder Biotech, Inc

🇺🇸 22 Strathmore Rd Natick, Massachusetts 01760, US

PeptiFinder Biotech specializes in biotechnology research, utilizing an innovative mRNA display platform to revolutionize drug discovery and provide cost-effective solutions for peptide optimization in early-stage development.

biotechnology
drug discovery
mRNA display
peptide optimization
target identification
hit-to-lead
early discovery
research platform
Company size: 2-10
Founded: 2023
Xellar Biosystems logo

Xellar Biosystems

🇺🇸 500 Rutherford Ave Boston, Massachusetts 02129, US

Xellar Biosystems specializes in biotechnology research, employing an innovative three-pronged approach to drug discovery that integrates Organ-on-a-Chip technology with artificial intelligence and machine learning. This unique methodology aims to address the complexities of human biology, significantly accelerating the drug discovery and development process.

biotechnology
drug discovery
Organ-on-a-Chip
artificial intelligence
machine learning
high throughput screening
morphological profiling
lab automation
microfluidics
3D cell culture
disease modeling
micro-physiological systems
Company size: 11-50
Founded: 2022
SAGEbio LLC logo

SAGEbio LLC

🇺🇸 1 Broadway 14th floor

SAGEbio LLC is focused on biotechnology research, specializing in the development of biopharmaceuticals, biologics, and biosimilars. Leveraging breakthrough technology, it aims to provide accelerated and cost-effective access to a range of biopharmaceuticals, including vaccines, particularly in the MENA region.

biopharmaceuticals
biologics
biosimilars
biotechnology
vaccines
health technology
MENA region
research and development
drug development
Company size: 2-10
Founded: 2022

Updated on

Let our AI browse all websites for you

Save time, improve accuracy, and get ahead of the competition with Cenco.ai.

Get started

You might be interested in